2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart …

CW Yancy, M Jessup, B Bozkurt, J Butler… - Journal of the American …, 2016 - jacc.org
The ACC, the AHA, and the Heart Failure Society of America (HFSA) recognize that the
introduction of effective new therapies that potentially affect a large number of patients …

[引用][C] 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of …

CW Yancy, M Jessup, B Bozkurt, J Butler… - Journal of the American …, 2016 - cir.nii.ac.jp
2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure:
An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure | CiNii …

[PDF][PDF] 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of …

CW Yancy, M Jessup, DE Casey, F JR MD… - JOURNAL OF THE …, 2016 - botonimarco.it
The ACC, the AHA, and the Heart Failure Society of America (HFSA) recognize that the
introduction of effective new therapies that potentially affect a large number of patients …

[PDF][PDF] 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of …

CW Yancy, DE Casey Jr, FA Masoudi, G Filippatos… - Circulation, 2016 - ww.solanomd.com
The ACC, the AHA, and the Heart Failure Society of America (HFSA) recognize that the
introduction of effective new therapies that potentially affect a large number of patients …

2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart …

CW Yancy, M Jessup, B Bozkurt… - Journal of Cardiac …, 2016 - ohsu.elsevierpure.com
2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An
Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the …

[PDF][PDF] 2016 ACC/AHA/HFSA Focused update on New pharmacological therapy for Heart Failure: An update of the 2013 ACCF/AHA Guideline for the Management of …

CW Yancy, DE Casey Jr, G Filippatos… - …, 2016 - emory.instructure.com
The ACC, the AHA, and the Heart Failure Society of America (HFSA) recognize that the
introduction of effective new therapies that potentially affect a large number of patients …

[PDF][PDF] 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of …

CW Yancy, M Jessup, DE Casey, F JR MD… - JOURNAL OF THE …, 2016 - ecgtraining.org
The ACC, the AHA, and the Heart Failure Society of America (HFSA) recognize that the
introduction of effective new therapies that potentially affect a large number of patients …

2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart …

WRITING COMMITTEE MEMBERS, CW Yancy… - Circulation, 2016 - Am Heart Assoc
The ACC, the AHA, and the Heart Failure Society of America (HFSA) recognize that the
introduction of effective new therapies that potentially affect a large number of patients …

[PDF][PDF] 2016 ACC/AHA/HFSA Focused update on New pharmacological therapy for Heart Failure: An update of the 2013 ACCF/AHA Guideline for the Management of …

CW Yancy, DE Casey Jr, G Filippatos, GC Fonarow… - Circulation, 2016 - gdpharmd.com
The ACC, the AHA, and the Heart Failure Society of America (HFSA) recognize that the
introduction of effective new therapies that potentially affect a large number of patients …

[PDF][PDF] 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of …

CW Yancy, DE Casey Jr, FA Masoudi… - …, 2016 - depts.washington.edu
The ACC, the AHA, and the Heart Failure Society of America (HFSA) recognize that the
introduction of effective new therapies that potentially affect a large number of patients …